Antidepressants, which they may need to take during pregnancy, have been linked to fetal malformations, cardiac defects, pulmonary hypertension, and reduced birth weight.
The annual growth rate reached its peak during the 1950s and has been declining since 1960, primarily because of a sharply reduced birth rate and continued emigration.
Mean PFOS concentrations exceeding 12.8 μg/L were seen to increase the risk of reduced birth weight of newborns.
Favored by increased life expectancy and reduced birth rate, worldwide demography is rapidly shifting to older ages.
It is already well established that smoking leads to reduced birth weight and an increased risk of premature birth.
However, a recent study from the UK showed that mothers exposed to SHS also demonstrate an increased risk of early delivery and reduced birth weight of infants [3].
Conclusion: Prolonged antenatal betamethasone therapy was not associated with higher risks of antenatal maternal fever, chorioamnionitis, reduced birth weight, neonatal adrenal suppression, neonatal sepsis, and neonatal death.
Conclusions: The reduced birth weight of the newborns in Denver was the result of a reduction in fetal subcutaneous fat tissue and not lean mass.
Prolonged antenatal betamethasone therapy was not associated with increases in incidences of antenatal fever, chorioamnionitis, reduced birth weight, suppressed neonatal adrenal function, neonatal sepsis, or neonatal death.
To evaluate insulin sensitivity (SI) in prepubertal twins and to examine the relation to reduced birth weight, prematurity, and peroxisome proliferator-activated receptor-γ (PPARγ) polymorphism.
Epidemiologically, nicotine content in cigarette is related to reduced birth length in humans [15].
